Abstract
Platelets play an important role in carcinogenesis, but the underlying molecular mechanisms remain poorly understood. To investigate the effects of platelets on in vitro invasion of MCF7 human breast cancer cells, human MCF7 cells were used to study their interactions with platelets using aggregometry and cell invasion chambers. Zymography and quantitative polymerase chain reaction (PCR) were used to study matrix metalloproteinases (MMPs), whereas Western blot was used to study protein kinase C (PKC) δ in MCF7 cells. We observed that platelets promoted invasion of MCF7 cells (3-fold increase, p < 0.05, n = 3) and that this process correlated with a dramatic increase in MMP-9 (8 fold-increase, p < 0.001, n = 3), which is known to facilitate cancer cell invasion. Because both platelets and MCF7 cells have been shown to release MMP-9, we investigated the cellular source that accounted for this increase. The time course and the use of specific protein synthesis inhibitors demonstrated that most of the increase in MMP-9 levels derived from de novo synthesis of this protease by cancer cells. Furthermore, platelets activated PKCδ in MCF7 cells after 1 h of incubation (18.45 ± 4.75% increase, p < 0.05, n = 4-7), which, in turn, led to an up-regulation of MMP-9 mRNA (from 60 ± 20 to 1040 ± 100 pg, p < 0.001, n = 3) and protein levels (18-fold increase, p < 0.001, n = 3), with the subsequent cell invasion-promoting effects. PKCδ plays a crucial role in transducing the invasion-promoting effects of platelets in breast cancer cells, and the specific inhibition of PKCδ may be a strategy to decrease platelet-mediated cancer cell invasion.
Footnotes
-
This work was supported by a Secretaria de Estado de Educacion y Universidades fellowship, cofunded by the European Social Fund to D.A.E. and C.M. (EX2004-0396). D.A.E. and C.M. are postdoctoral fellows of Spanish Ministry of Education. M.J.S.-M. was supported by grants from Fundacio Catalana de Pneumologia (FUCAP), Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), and Societat Catalana de Pneumologia (SOCAP), Spain.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.106.103358.
-
ABBREVIATIONS: TCIPA, tumor cell-induced platelet aggregation; ECM, extracellular matrix; MMP, matrix metalloproteinase; PKC, protein kinase C; MT1, membrane type 1; Gö6976, 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c] carbazole; DMEM, Dulbecco's minimum essential medium; MEM, minimum essential medium; FBS, fetal bovine serum; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; GSNO, S-nitrosoglutathione; PCR, polymerase chain reaction; qPCR, quantitative PCR.
- Received February 22, 2006.
- Accepted April 13, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|